PF-04427429
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-04427429, covering 2012-01-18 to 2013-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers [Phase 1]